05/06/2025 3:41 PM | Akero Therapeutics (Subject) Rolph Timothy (Reporting)
| Form 144 Notice of proposed sale of securities pursuant to Rule 144 | |
04/28/2025 5:22 PM | Akero Therapeutics (Issuer) Rolph Timothy (Reporting)
| Form 4 Statement of changes in beneficial ownership of securities | |
04/28/2025 7:00 AM | Akero Therapeutics (Filer)
| Form DEF 14A | |
04/28/2025 7:23 AM | Akero Therapeutics (Filer)
| Form ARS | |
04/16/2025 5:00 PM | Akero Therapeutics (Issuer) Yale Catriona (Reporting)
| Form 4 Statement of changes in beneficial ownership of securities | |
04/11/2025 5:00 PM | Akero Therapeutics (Issuer) Cheng Andrew (Reporting)
| Form 4 Statement of changes in beneficial ownership of securities | |
04/10/2025 5:00 PM | Akero Therapeutics (Issuer) Rolph Timothy (Reporting)
| Form 4 Statement of changes in beneficial ownership of securities | |
04/07/2025 3:24 PM | Akero Therapeutics (Subject) Lamy Patrick (Reporting)
| Form 144 Notice of proposed sale of securities pursuant to Rule 144 | |
03/27/2025 6:42 PM | Akero Therapeutics (Issuer) Graham G. Walmsley (Reporting)
| Form 4 Statement of changes in beneficial ownership of securities | |
03/18/2025 4:30 PM | Akero Therapeutics (Issuer) Yale Catriona (Reporting)
| Form 4 Statement of changes in beneficial ownership of securities | |
03/14/2025 8:18 PM | Akero Therapeutics (Issuer) Cheng Andrew (Reporting)
| Form 4 Statement of changes in beneficial ownership of securities | |
Get the Latest News and Ratings for AKRO and Related Stocks Enter your email address below to receive the latest news and analysts' ratings for Akero Therapeutics and its competitors with MarketBeat's FREE daily newsletter.
|
03/14/2025 7:24 PM | Akero Therapeutics (Issuer) White William Richard (Reporting)
| Form 4 Statement of changes in beneficial ownership of securities | |
03/14/2025 7:30 PM | Akero Therapeutics (Issuer) Yale Catriona (Reporting)
| Form 4 Statement of changes in beneficial ownership of securities | |
03/14/2025 7:33 PM | Akero Therapeutics (Issuer) Young Jonathan (Reporting)
| Form 4 Statement of changes in beneficial ownership of securities | |
03/14/2025 7:18 PM | Akero Therapeutics (Issuer) Rolph Timothy (Reporting)
| Form 4 Statement of changes in beneficial ownership of securities | |
03/12/2025 5:00 PM | Akero Therapeutics (Issuer) Cheng Andrew (Reporting)
| Form 4 Statement of changes in beneficial ownership of securities | |
03/07/2025 4:30 PM | Akero Therapeutics (Issuer) Rolph Timothy (Reporting)
| Form 4 Statement of changes in beneficial ownership of securities | |
03/05/2025 5:55 PM | Akero Therapeutics (Issuer) Lamy Patrick (Reporting)
| Form 4 Statement of changes in beneficial ownership of securities | |
03/05/2025 5:56 PM | Akero Therapeutics (Issuer) Young Jonathan (Reporting)
| Form 4 Statement of changes in beneficial ownership of securities | |
02/28/2025 3:05 PM | Akero Therapeutics (Filer)
| Form S-8 Registration statement under Securities Act of 1933 to be offered to employees pursuant to certain plans | |
02/28/2025 7:30 AM | Akero Therapeutics (Filer)
| Form 8-K Current report pursuant to Section 13 or 15(d) | |
02/28/2025 6:30 AM | Akero Therapeutics (Filer)
| Form 10-K Annual report pursuant to Section 13 or 15(d) | |
02/21/2025 4:31 PM | Akero Therapeutics (Issuer) Yale Catriona (Reporting)
| Form 4 Statement of changes in beneficial ownership of securities | |
02/14/2025 11:58 AM | Akero Therapeutics (Subject) JANUS HENDERSON GROUP PLC (Filed by)
| Form SCHEDULE 13G/A | |
02/14/2025 8:00 AM | Akero Therapeutics (Subject) RTW INVESTMENTS, LP (Filed by)
| Form SCHEDULE 13G/A | |
02/11/2025 8:30 PM | Akero Therapeutics (Issuer) Cheng Andrew (Reporting)
| Form 4 Statement of changes in beneficial ownership of securities | |
02/07/2025 6:54 PM | Akero Therapeutics (Issuer) Graham G. Walmsley (Reporting)
| Form 4 Statement of changes in beneficial ownership of securities | |
02/07/2025 5:05 PM | Akero Therapeutics (Issuer) Rolph Timothy (Reporting)
| Form 4 Statement of changes in beneficial ownership of securities | |
02/05/2025 8:03 AM | Akero Therapeutics (Issuer) Young Jonathan (Reporting)
| Form 4 Statement of changes in beneficial ownership of securities | |
01/31/2025 8:14 AM | Akero Therapeutics (Issuer) Yale Catriona (Reporting)
| Form 4 Statement of changes in beneficial ownership of securities | |
01/31/2025 8:14 AM | Akero Therapeutics (Issuer) Yale Catriona (Reporting)
| Form 4 Statement of changes in beneficial ownership of securities | |
01/30/2025 6:52 AM | Akero Therapeutics (Filer)
| Form 8-K Current report pursuant to Section 13 or 15(d) | |
01/29/2025 7:43 PM | Akero Therapeutics (Issuer) Cheng Andrew (Reporting)
| Form 4 Statement of changes in beneficial ownership of securities | |
01/29/2025 7:43 PM | Akero Therapeutics (Issuer) Lamy Patrick (Reporting)
| Form 4 Statement of changes in beneficial ownership of securities | |
01/29/2025 7:43 PM | Akero Therapeutics (Issuer) Rolph Timothy (Reporting)
| Form 4 Statement of changes in beneficial ownership of securities | |
01/29/2025 4:08 PM | Akero Therapeutics (Filer)
| Form 424B5 | |
01/27/2025 8:35 PM | Akero Therapeutics (Subject)
| Form FWP | |
01/27/2025 5:07 PM | Akero Therapeutics (Issuer) Cheng Andrew (Reporting)
| Form 4 Statement of changes in beneficial ownership of securities | |
01/27/2025 5:08 PM | Akero Therapeutics (Issuer) Young Jonathan (Reporting)
| Form 4 Statement of changes in beneficial ownership of securities | |
01/27/2025 3:53 PM | Akero Therapeutics (Filer)
| Form 424B5 | |
01/27/2025 3:23 PM | Akero Therapeutics (Subject) Lamy Patrick (Reporting)
| Form 144 Notice of proposed sale of securities pursuant to Rule 144 | |
Here’s How to Claim Your Stake in Elon’s Private Company, xAI (Ad) Even though xAI is a private company, tech legend and angel investor Jeff Brown found a way for everyday folks like you…
To partner with Elon on what he believes will be the biggest AI project of the century…
Starting with as little as $500. Click here to see how you could take a stake in Elon’s private company… |
01/27/2025 3:24 PM | Akero Therapeutics (Subject) Yale Catriona (Reporting)
| Form 144 Notice of proposed sale of securities pursuant to Rule 144 | |
01/27/2025 3:24 PM | Akero Therapeutics (Subject) Yale Catriona (Reporting)
| Form 144 Notice of proposed sale of securities pursuant to Rule 144 | |
01/27/2025 3:06 PM | Akero Therapeutics (Subject) Rolph Timothy (Reporting)
| Form 144 Notice of proposed sale of securities pursuant to Rule 144 | |
01/27/2025 7:31 AM | Akero Therapeutics (Filer)
| Form 8-K Current report pursuant to Section 13 or 15(d) | |
01/10/2025 6:38 PM | Akero Therapeutics (Issuer) Rolph Timothy (Reporting)
| Form 4 Statement of changes in beneficial ownership of securities | |
01/06/2025 1:08 PM | Akero Therapeutics (Issuer) Young Jonathan (Reporting)
| Form 4 Statement of changes in beneficial ownership of securities | |
12/30/2024 7:20 PM | Akero Therapeutics (Issuer) Rolph Timothy (Reporting)
| Form 4 Statement of changes in beneficial ownership of securities | |
12/18/2024 7:59 PM | Akero Therapeutics (Issuer) White William Richard (Reporting)
| Form 4 Statement of changes in beneficial ownership of securities | |
12/18/2024 8:01 PM | Akero Therapeutics (Issuer) Yale Catriona (Reporting)
| Form 4 Statement of changes in beneficial ownership of securities | |
12/18/2024 8:03 PM | Akero Therapeutics (Issuer) Lamy Patrick (Reporting)
| Form 4 Statement of changes in beneficial ownership of securities | |
12/18/2024 8:08 PM | Akero Therapeutics (Issuer) Young Jonathan (Reporting)
| Form 4 Statement of changes in beneficial ownership of securities | |
12/18/2024 7:50 PM | Akero Therapeutics (Issuer) Cheng Andrew (Reporting)
| Form 4 Statement of changes in beneficial ownership of securities | |
12/18/2024 7:52 PM | Akero Therapeutics (Issuer) Rolph Timothy (Reporting)
| Form 4 Statement of changes in beneficial ownership of securities | |
12/18/2024 7:56 PM | Akero Therapeutics (Issuer) Gangloff Scott A. (Reporting)
| Form 4 Statement of changes in beneficial ownership of securities | |
12/12/2024 7:38 PM | Akero Therapeutics (Issuer) Young Jonathan (Reporting)
| Form 4 Statement of changes in beneficial ownership of securities | |
12/12/2024 7:44 PM | Akero Therapeutics (Issuer) Rolph Timothy (Reporting)
| Form 4 Statement of changes in beneficial ownership of securities | |
12/12/2024 7:24 PM | Akero Therapeutics (Issuer) Cheng Andrew (Reporting)
| Form 4 Statement of changes in beneficial ownership of securities | |
12/12/2024 7:26 PM | Akero Therapeutics (Issuer) White William Richard (Reporting)
| Form 4 Statement of changes in beneficial ownership of securities | |
12/12/2024 7:28 PM | Akero Therapeutics (Issuer) Yale Catriona (Reporting)
| Form 4 Statement of changes in beneficial ownership of securities | |
12/12/2024 7:29 PM | Akero Therapeutics (Issuer) Lamy Patrick (Reporting)
| Form 4 Statement of changes in beneficial ownership of securities | |
12/10/2024 3:25 PM | Akero Therapeutics (Subject) Rolph Timothy (Reporting)
| Form 144 Notice of proposed sale of securities pursuant to Rule 144 | |
11/19/2024 8:57 PM | Akero Therapeutics (Issuer) Yale Catriona (Reporting)
| Form 4 Statement of changes in beneficial ownership of securities | |
11/14/2024 5:51 AM | Akero Therapeutics (Subject) RTW INVESTMENTS, LP (Filed by)
| Form SC 13G/A | |
11/13/2024 8:45 AM | Akero Therapeutics (Subject) ALKEON CAPITAL MANAGEMENT LLC (Filed by)
| Form SC 13G/A | |
11/08/2024 4:06 PM | Akero Therapeutics (Issuer) Yale Catriona (Reporting)
| Form 4 Statement of changes in beneficial ownership of securities | |
11/08/2024 9:52 AM | Akero Therapeutics (Subject) WELLINGTON MANAGEMENT GROUP LLP (Filed by)
| Form SC 13G/A | |
11/08/2024 6:30 AM | Akero Therapeutics (Filer)
| Form 10-Q General form for quarterly reports under Section 13 or 15(d) | |
11/08/2024 6:19 AM | Akero Therapeutics (Filer)
| Form 8-K Current report pursuant to Section 13 or 15(d) | |
11/06/2024 4:01 PM | Akero Therapeutics (Subject) Yale Catriona (Reporting)
| Form 144 Notice of proposed sale of securities pursuant to Rule 144 | |
11/05/2024 8:00 AM | Akero Therapeutics (Issuer) Cheng Andrew (Reporting)
| Form 4 Statement of changes in beneficial ownership of securities | |
11/05/2024 8:04 AM | Akero Therapeutics (Issuer) Young Jonathan (Reporting)
| Form 4 Statement of changes in beneficial ownership of securities | |
11/01/2024 7:59 PM | Akero Therapeutics (Issuer) Yale Catriona (Reporting)
| Form 4 Statement of changes in beneficial ownership of securities | |
11/01/2024 3:46 PM | Akero Therapeutics (Subject) Yale Catriona (Reporting)
| Form 144 Notice of proposed sale of securities pursuant to Rule 144 | |
10/18/2024 7:57 PM | Akero Therapeutics (Issuer) Cheng Andrew (Reporting)
| Form 4 Statement of changes in beneficial ownership of securities | |
10/17/2024 10:13 AM | Akero Therapeutics (Subject) STATE STREET CORP (Filed by)
| Form SC 13G/A | |
10/16/2024 7:06 PM | Akero Therapeutics (Issuer) Yale Catriona (Reporting)
| Form 4 Statement of changes in beneficial ownership of securities | |
10/16/2024 7:06 PM | Akero Therapeutics (Issuer) Young Jonathan (Reporting)
| Form 4 Statement of changes in beneficial ownership of securities | |
10/16/2024 3:50 PM | Akero Therapeutics (Subject) Cheng Andrew (Reporting)
| Form 144 Notice of proposed sale of securities pursuant to Rule 144 | |
10/15/2024 3:38 PM | Akero Therapeutics (Subject) Yale Catriona (Reporting)
| Form 144 Notice of proposed sale of securities pursuant to Rule 144 | |
10/15/2024 7:04 AM | Akero Therapeutics (Subject) Yale Catriona (Reporting)
| Form 144 Notice of proposed sale of securities pursuant to Rule 144 | |
10/03/2024 7:09 PM | Akero Therapeutics (Issuer) Young Jonathan (Reporting)
| Form 4 Statement of changes in beneficial ownership of securities | |
10/01/2024 3:03 PM | Akero Therapeutics (Subject) Young Jonathan (Reporting)
| Form 144 Notice of proposed sale of securities pursuant to Rule 144 | |
09/23/2024 5:00 PM | Akero Therapeutics (Issuer) Yale Catriona (Reporting)
| Form 4 Statement of changes in beneficial ownership of securities | |
09/18/2024 8:19 PM | Akero Therapeutics (Issuer) Yale Catriona (Reporting)
| Form 4 Statement of changes in beneficial ownership of securities | |
09/16/2024 3:34 PM | Akero Therapeutics (Subject) Yale Catriona (Reporting)
| Form 144 Notice of proposed sale of securities pursuant to Rule 144 | |
09/13/2024 4:14 PM | Akero Therapeutics (Issuer) Yale Catriona (Reporting)
| Form 4 Statement of changes in beneficial ownership of securities | |
09/13/2024 4:16 PM | Akero Therapeutics (Issuer) Young Jonathan (Reporting)
| Form 4 Statement of changes in beneficial ownership of securities | |
09/13/2024 4:10 PM | Akero Therapeutics (Issuer) Cheng Andrew (Reporting)
| Form 4 Statement of changes in beneficial ownership of securities | |
09/13/2024 4:11 PM | Akero Therapeutics (Issuer) Rolph Timothy (Reporting)
| Form 4 Statement of changes in beneficial ownership of securities | |
09/13/2024 4:13 PM | Akero Therapeutics (Issuer) White William Richard (Reporting)
| Form 4 Statement of changes in beneficial ownership of securities | |
Virtually Limitless Energy? (Ad) A radical energy breakthrough could change everything. Scientists at MIT and a stealth startup may have discovered a new form of power—what some are calling “Helios” technology. It’s not solar, wind, or even nuclear fission. In fact, it could yield more energy than oil, gas, and coal combined—without harmful byproducts.
This obscure company could be at the center of the next trillion-dollar energy revolution. One company’s discovery could change power forever |
09/09/2024 8:09 AM | Akero Therapeutics (Subject) WELLINGTON MANAGEMENT GROUP LLP (Filed by)
| Form SC 13G/A | |
09/05/2024 3:05 PM | Akero Therapeutics (Issuer) Yale Catriona (Reporting)
| Form 4 Statement of changes in beneficial ownership of securities | |
09/05/2024 3:08 PM | Akero Therapeutics (Issuer) Young Jonathan (Reporting)
| Form 4 Statement of changes in beneficial ownership of securities | |
08/29/2024 3:30 PM | Akero Therapeutics (Issuer) White William Richard (Reporting)
| Form 4 Statement of changes in beneficial ownership of securities | |
08/28/2024 10:11 AM | Akero Therapeutics (Issuer) Yale Catriona (Reporting)
| Form 4 Statement of changes in beneficial ownership of securities | |
08/26/2024 3:32 PM | Akero Therapeutics (Subject) White William Richard (Reporting)
| Form 144 Notice of proposed sale of securities pursuant to Rule 144 | |
08/23/2024 3:27 PM | Akero Therapeutics (Subject) Yale Catriona (Reporting)
| Form 144 Notice of proposed sale of securities pursuant to Rule 144 | |
08/20/2024 10:45 AM | Akero Therapeutics (Issuer) Cheng Andrew (Reporting)
| Form 4 Statement of changes in beneficial ownership of securities | |
08/09/2024 6:30 AM | Akero Therapeutics (Filer)
| Form 10-Q General form for quarterly reports under Section 13 or 15(d) | |